Clin Microbiol Rev 2003, 16:175–188.PubMedCrossRef 35. Lefebvre B, Malouin F, Roy G, Giguere K, Diarra MS: Growth performance and shedding of some pathogenic bacteria in feedlot cattle treated with different growth-promoting #SIS3 randurls[1|1|,|CHEM1|]# agents. J Food Prot 2006, 6:1256–1264. 36. Hoyle DV, Davison HC, Knight HI, Yates CM, Dobay O, Gunn GJ, Amyes SGB, Woolhouse MEJ: Molecular characterisation of bovine faecal Escherichia coli shows persistence

of defined ampicillin resistant strains and the presence of class 1 integrons on an organic beef farm. Vet Microbiol 2006, 115:250–257.PubMedCrossRef 37. Berge AC, Atwill ER, Sischo WM: Animal and farm influences on the dynamics of antibiotic resistance in faecal Escherichia coli in young dairy calves. Prev Vet Med 2005, 69:25–38.PubMedCrossRef 38. Hinton M, Linton AH, Hedges AJ: The ecology of Escherichia coli in calves reared as dairy-cow replacements. J Appl Bacteriol 1985, 58:131–138.PubMed 39. Galland JC, Hyatt DR, Crupper SS, Acheson DW: Prevalence,

antibiotic susceptibility and diversity of Esherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots. Appl Environ Microbiol 2001, 67:1619–1627.PubMedCrossRef selleck chemicals 40. Checkley SL, Campbell JR, Chirino-Trejo M, Janzen ED, Waldner CL: Association between antimicrobial use and the prevalence of antimicrobial resistance in fecal Escherichia coli from feedlot cattle in western Canada. Can Vet J 2010, 51:853–861.PubMed 41. Stokes DJ, Kelly AF, Gould SWJ, Cassar CA, Fielder MD: The withdrawal of antimicrobial treatment as a mechanism for defeating

resistant microorganisms. FEMS Imnun Med Microbiol 2008, 53:300–305.CrossRef 42. Guerra B, Junker E, Schroeter A, Malorny B, Lehmann S, Helmuth R: Phenotypic and genotypic characterization of antimicrobial resistance in German Escherichia coli isolates from cattle, swine and poultry. J Antimicrob Chemother 2003, 52:489–492.PubMedCrossRef 43. Enne VI, Livermore DM, Stephens P, Hall LM: Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 2001, 357:1325–1328.PubMedCrossRef 44. Enne VI, Bennett PM, Livermore DM, Hall LM: Enhancement of host fitness by the sul2-coding plasmid p9123 in the absence of selective tuclazepam pressure. J Antimicrob Chemother 2004, 53:958–963.PubMedCrossRef 45. Sherley M, Gordon DM, Collignon PJ: Evolution of multi-resistance plasmids in Australian clinical isolates of Escherichia coli . Microbiology 2004, 150:1539–1546.PubMedCrossRef 46. Singer RS, Ward MP, Maldonado G: Can landscape ecology untangle the complexity of antibiotic resistance? Nature Rev Microbiol 2006, 4:943–952.CrossRef 47. Rice DH, McMenamin KM, Pritchett LC, Hancock DD, Besser TE: Genetic subtyping of Escherichia coli O157:H7 isolates from 41 Pacific Northwest USA cattle farms. Epidemiol Infect 1999, 122:479–484.PubMedCrossRef 48.